ow dose of lenalidomide and dexamethasone therapy for eldery multiple myeloma
Not Applicable
Recruiting
- Conditions
- Refractory or relapsed symptomatic multiple myeloma
- Registration Number
- JPRN-UMIN000008918
- Lead Sponsor
- ishiwaki municipal hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 26
Inclusion Criteria
Not provided
Exclusion Criteria
*Patients who have allergy for the drugs used in this study *Patients who have active infectious disease *Patients who are decided as inappropriate by corresponding doctor.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Partial remission rate within a year after the therapy
- Secondary Outcome Measures
Name Time Method